The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasis (vol 1, pg 1, 2017)

被引：0

|

作者：

Yiu, Z. Z.

Warren, R. B.

机构：

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2017年 / 26卷 / 02期

关键词：

D O I：

10.1080/13543784.2017.1280117

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：263 / 263

页数：1

相关论文

共 50 条

[31] European S3-Guidelines on the systemic treatment of psoriasis vulgaris. (vol 23, pg 1, 2009)
Pathirana, D.
Ormerod, A. D.
Saiag, P.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (01) : 117 - 118
[32] Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn’s Disease: Analyses of Phase I and II Trials
Ahmed A. Suleiman
Amit Khatri
Mukul Minocha
Ahmed A. Othman
Clinical Pharmacokinetics, 2019, 58 : 375 - 387
[33] Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab
Mansouri, B.
Richards, L.
Menter, A.
BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (01) : 239 - 241
[34] A new class of therapeutic biologic agents for combatting psoriasis: anti-IL-23 agents (vol 6, pg 1, 2017)
Tonini, A.
Gualtieri, B.
Panduri, S.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (02) : 227 - 227
[35] Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells (vol 33, pg 279, 2010)
Ahern, Philip P.
Schiering, Chris
Buonocore, Sofia
McGeachy, Mandy J.
Cua, Dan J.
Maloy, Kevin J.
Powrie, Fiona
IMMUNITY, 2011, 34 (03) : 448 - 448
[36] The Utility of long-Term Number Needed to Treat to Evaluate Interleukin 17 and 23 Inhibitor Therapies in the Treatment of Moderate to Severe Plaque Psoriasis
Gonzalez-Dominguez, A.
Garcia-Agua, N.
Dauden, E.
Ventayol-Bosch, P.
ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (04): : 427 - 429
[37] ANALYSIS OF INTERLEUKIN-17, INTERLEUKIN-23, NEOPTERIN AND NESFATIN-1 LEVELS IN THE SERA OF HASHIMOTO PATIENTS
Bayraktar, Nihayet
Eren, Mehmet Ali
Bayraktar, Mustafa
Ozturk, Ali
Erdogdu, Hamza
JOURNAL OF MEDICAL BIOCHEMISTRY, 2023, 42 (03) : 460 - 468
[38] RETRACTION: Exercise as antidepressant treatment: Time for the transition from trials to clinic? (vol 49, pg 1, 2017) (Retraction of Vol 49, Pg 1, 2017)
Ekkekakis, Panteleimon
Murri, Martino Belvederi
GENERAL HOSPITAL PSYCHIATRY, 2017, 49 : 1 - 1
[39] Editorial (vol 23, pg 1, 2021)
Hart, Paul J. B.
FISH AND FISHERIES, 2022, 23 (04) : 1024 - 1024
[40] The Feller diffusion, filter rules and abnormal stock returns (vol 23, pg 1, 2017)
Docherty, Paul
Dong, Yizhe
Song, Xiaojing
Tippett, Mark
EUROPEAN JOURNAL OF FINANCE, 2017, 23 (14):

← 1 2 3 4 5 →